.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
McKesson
Express Scripts
Baxter
McKinsey
Accenture
Argus Health
Cerilliant
Cantor Fitzgerald
Federal Trade Commission

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020330

« Back to Dashboard

NDA 020330 describes TIMOPTIC-XE, which is a drug marketed by Valeant Pharms Llc and is included in one NDA. It is available from three suppliers. Additional details are available on the TIMOPTIC-XE profile page.

The generic ingredient in TIMOPTIC-XE is timolol maleate. There are fifteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the timolol maleate profile page.

Summary for 020330

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antimigraine Agents
Cardiovascular Agents
Ophthalmic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 020330

Mechanism of ActionAdrenergic beta-Antagonists

Suppliers and Packaging for NDA: 020330

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TIMOPTIC-XE timolol maleate SOLUTION, GEL FORMING/DROPS;OPHTHALMIC 020330 NDA Bausch & Lomb Incorporated 24208-814 24208-814-25 1 BOTTLE, DISPENSING in 1 CARTON (24208-814-25) > 5 mL in 1 BOTTLE, DISPENSING
TIMOPTIC-XE timolol maleate SOLUTION, GEL FORMING/DROPS;OPHTHALMIC 020330 NDA Bausch & Lomb Incorporated 24208-816 24208-816-05 1 BOTTLE, DISPENSING in 1 CARTON (24208-816-05) > 5 mL in 1 BOTTLE, DISPENSING

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION, GEL FORMING/DROPS;OPHTHALMICStrengthEQ 0.25% BASE
Approval Date:Nov 4, 1993TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:SOLUTION, GEL FORMING/DROPS;OPHTHALMICStrengthEQ 0.5% BASE
Approval Date:Nov 4, 1993TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 020330

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms LlcTIMOPTIC-XEtimolol maleateSOLUTION, GEL FORMING/DROPS;OPHTHALMIC020330-001Nov 4, 1993► Subscribe► Subscribe
Valeant Pharms LlcTIMOPTIC-XEtimolol maleateSOLUTION, GEL FORMING/DROPS;OPHTHALMIC020330-002Nov 4, 1993► Subscribe► Subscribe
Valeant Pharms LlcTIMOPTIC-XEtimolol maleateSOLUTION, GEL FORMING/DROPS;OPHTHALMIC020330-002Nov 4, 1993► Subscribe► Subscribe
Valeant Pharms LlcTIMOPTIC-XEtimolol maleateSOLUTION, GEL FORMING/DROPS;OPHTHALMIC020330-001Nov 4, 1993► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Baxter
Medtronic
Healthtrust
Chubb
Julphar
Chinese Patent Office
Daiichi Sankyo
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot